Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125433594 | 12543359 | 4 | F | 20160603 | 20160901 | 20160711 | 20160909 | EXP | CA-AMGEN-CANSP2016082789 | AMGEN | 75.00 | YR | E | M | Y | 0.00000 | 20160908 | CN | CA | CA |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125433594 | 12543359 | 1 | PS | ENBREL | ETANERCEPT | 1 | Subcutaneous | 50 MG, QWK | 103795 | 50 | MG | UNKNOWN FORMULATION | /wk | ||||||
125433594 | 12543359 | 2 | SS | METHOTREXATE. | METHOTREXATE | 1 | Oral | UP TO 25 MG QWK | 0 | ||||||||||
125433594 | 12543359 | 3 | SS | SULFASALAZINE. | SULFASALAZINE | 1 | Oral | 1 G, BID | 0 | 1 | G | BID | |||||||
125433594 | 12543359 | 4 | SS | PLAQUENIL | HYDROXYCHLOROQUINE SULFATE | 1 | Unknown | UNK | 0 | ||||||||||
125433594 | 12543359 | 5 | SS | ARAVA | LEFLUNOMIDE | 1 | Unknown | 0 | |||||||||||
125433594 | 12543359 | 6 | SS | RITUXAN | RITUXIMAB | 1 | Unknown | UNK | 0 | ||||||||||
125433594 | 12543359 | 7 | SS | GOLD | GOLD | 1 | Unknown | 0 | |||||||||||
125433594 | 12543359 | 8 | C | PREDNISONE. | PREDNISONE | 1 | Unknown | 10 MG, QWK | 0 | 10 | MG | /wk | |||||||
125433594 | 12543359 | 9 | C | CELEXA | CITALOPRAM HYDROBROMIDE | 1 | Unknown | 40 MG, QWK | 0 | 40 | MG | /wk |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125433594 | 12543359 | 1 | Rheumatoid arthritis |
125433594 | 12543359 | 2 | Rheumatoid arthritis |
125433594 | 12543359 | 3 | Rheumatoid arthritis |
125433594 | 12543359 | 4 | Product used for unknown indication |
125433594 | 12543359 | 5 | Product used for unknown indication |
125433594 | 12543359 | 6 | Product used for unknown indication |
125433594 | 12543359 | 7 | Product used for unknown indication |
125433594 | 12543359 | 8 | Product used for unknown indication |
125433594 | 12543359 | 9 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125433594 | 12543359 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125433594 | 12543359 | Arthralgia | |
125433594 | 12543359 | Back pain | |
125433594 | 12543359 | Depression | |
125433594 | 12543359 | Limb deformity | |
125433594 | 12543359 | Musculoskeletal pain | |
125433594 | 12543359 | Pain in extremity | |
125433594 | 12543359 | Rash | |
125433594 | 12543359 | Skin cancer | |
125433594 | 12543359 | Squamous cell carcinoma |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125433594 | 12543359 | 6 | 201508 | 0 |